A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

Status:
Active, not recruiting

Trial end date:
2022-04-30

Target enrollment:

Participant gender:

The purpose of this tria is to evaluate the safety and efficacy of long-term treatment with NPC-12G gel to patients with neurofibromatosis type I.

Phase 3

Nobelpharma